Sunitinib Treatment Exacerbates Intratumoral Heterogeneity in Metastatic Renal CancerGrant D. Stewart, Thomas Powles, Antony C. P. Riddick et al.|Clinical Cancer Research|2015Cited by 45
Integrated, High-Throughput, Multiomics Platform Enables Data-Driven Construction of Cellular Responses and Reveals Global Drug Mechanisms of ActionJeremy L. Norris, Richard M. Caprioli, Melissa A. Farrow et al.|Journal of Proteome Research|2017Cited by 44
Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor–Targeted Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal CancerGrant D. Stewart, Thomas Powles, Fiach C. O’Mahony et al.|European Urology|2014Cited by 43
Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced DifferentiationHaley E. Ramsey, Michael R. Savona, Kristy R. Stengel et al.|Targeted Oncology|2021Cited by 3
The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.Grant Stewart, Tom Powles, Alexander Laird et al.|Journal of Clinical Oncology|2014Cited by 2